Skip to main content

Table 1 Characteristics of participants in cases of acute coronary syndrome and controls

From: Circulating metabolites from the choline pathway and acute coronary syndromes in a Chinese case-control study

Characteristics

Total (n = 501)

Cases (n = 254)

Controls (n = 247)

p value

Age, mean (SD), year

62.92 ± 10.84

63.07 ± 11.02

62.77 ± 10.69

0.54

Sex male, No. (%)

430(85.8%)

217(85.4%)

213(86.2%)

0.90

Current smokers, No. (%)

163(32.5%)

110(43.3%)

53(21.5%)

< 0.001

Hypertension, No. (%)

296(59.1%)

149(58.7%)

147(59.5%)

0.92

Diabetes mellitus, No. (%)

104(20.8%)

71(28.0%)

33(13.4%)

< 0.001

Hyperlipidaemia, No. (%)

13(2.6%)

5(2.0%)

8(3.2%)

0.54

BMI, mean (SD), kg/m2

25.06 ± 3.33

24.73 ± 3.53

25.41 ± 3.08

0.02

Smoking Index, mean (SD), pack-years

15.13 ± 25.21

17.96 ± 26.37

12.22 ± 23.73

< 0.001

eGFR, mean (SD), ml/min/1.73m2

82.36 ± 19.90

80.76 ± 20.79

84.01 ± 18.88

0.07

Gensini Score, mean (SD)

39.88 ± 52.01

76.73 ± 50.83

1.99 ± 2.90

< 0.001

Betaine, mean (SD), μmol/L

40.07 ± 15.94

41.74 ± 17.87

38.36 ± 13.55

0.02

Choline, mean (SD), μmol/L

47.93 ± 33.26

57.04 ± 34.70

38.55 ± 28.99

< 0.001

TMA, mean (SD), μmol/L

4.10 ± 2.99

4.27 ± 3.30

3.93 ± 2.63

0.20

TMAO, mean (SD), μmol/L

1.92 ± 2.08

1.84 ± 2.21

1.99 ± 1.95

0.42

Choline metabolite score, mean (SD)

34.58 ± 21.33

40.21 ± 22.39

28.78 ± 18.56

< 0.001

Ratio of betaine/choline, mean (SD), μmol/L

1.03 ± 0.44

0.89 ± 0.43

1.18 ± 0.40

< 0.05

  1. BMI body mass index, eGFR estimated glomerular filtration rate, TMA trimethylamine, TMAO trimethylamine N-oxide
  2. Choline metabolite score was applied by a weighted sum of concentrations of four metabolites in the choline pathway (betaine, choline, TMA and TMAO)